These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26827949)

  • 21. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands.
    Carlberg C
    Recent Results Cancer Res; 2003; 164():29-42. PubMed ID: 12899512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor.
    Yamamoto K; Sun WY; Ohta M; Hamada K; DeLuca HF; Yamada S
    J Med Chem; 1996 Jul; 39(14):2727-37. PubMed ID: 8709103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
    Seuter S; Pehkonen P; Heikkinen S; Carlberg C
    Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells.
    Iwaki M; Kanemoto Y; Sawada T; Nojiri K; Kurokawa T; Tsutsumi R; Nagasawa K; Kato S
    PLoS One; 2023; 18(12):e0295288. PubMed ID: 38091304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and the Anticancer Activity of Vitamin D Receptor Agonists.
    Powała A; Żołek T; Brown G; Kutner A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel screening system for high-affinity ligand of heredity vitamin D-resistant rickets-associated vitamin D receptor mutant R274L using bioluminescent sensor.
    Mano H; Nishikawa M; Yasuda K; Ikushiro S; Saito N; Sawada D; Honzawa S; Takano M; Kittaka A; Sakaki T
    J Steroid Biochem Mol Biol; 2017 Mar; 167():61-66. PubMed ID: 27864003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures of hereditary vitamin D-resistant rickets-associated vitamin D receptor mutants R270L and W282R bound to 1,25-dihydroxyvitamin D3 and synthetic ligands.
    Nakabayashi M; Tsukahara Y; Iwasaki-Miyamoto Y; Mihori-Shimazaki M; Yamada S; Inaba S; Oda M; Shimizu M; Makishima M; Tokiwa H; Ikura T; Ito N
    J Med Chem; 2013 Sep; 56(17):6745-60. PubMed ID: 23944708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Structural refinement of seco-steroidal skeleton and the biological activity through nuclear receptors].
    Kittaka A
    Yakugaku Zasshi; 2008 Sep; 128(9):1235-50. PubMed ID: 18758137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
    Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
    Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N; Dutta A; Ray R
    Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.
    Slominski AT; Kim TK; Hobrath JV; Oak ASW; Tang EKY; Tieu EW; Li W; Tuckey RC; Jetten AM
    J Steroid Biochem Mol Biol; 2017 Oct; 173():42-56. PubMed ID: 27693422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.
    Rochel N; Wurtz JM; Mitschler A; Klaholz B; Moras D
    Mol Cell; 2000 Jan; 5(1):173-9. PubMed ID: 10678179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
    Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
    J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.